Patents by Inventor Robert Charles Rees

Robert Charles Rees has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • BREAST CANCER ASSOCIATED ANTIGEN
    Publication number: 20110052593
    Abstract: The invention relates to nucleic acid and amino acid sequences encoding BUC11 (SEQ ID NO: 36), BUC6 (SEQ ID NO: 31), BUC9 (SEQ ID NO: 32), and BUC10 (SEQ ID NO: 35), and to the use of such sequences in the identification and treatment of cancers.
    Type: Application
    Filed: October 15, 2008
    Publication date: March 3, 2011
    Inventors: Robert Charles Rees, Stephanie A.S. Laversin
  • Gastric and Prostate Cancer Associated Antigens
    Publication number: 20100297136
    Abstract: The invention relates to an antigen associated with cancers such as prostate and gastric cancers, known as T21. Nucleic acid sequences and polypeptide sequences encoding the antigen are provided, as are uses of such sequences.
    Type: Application
    Filed: April 21, 2010
    Publication date: November 25, 2010
    Inventors: Robert Charles Rees, Geng Li, Amanda Miles
  • PROSTATIC ACID PHOSPHATASE ANTIGENS
    Publication number: 20100278849
    Abstract: The invention relates to peptides from Prostatic Acid Phosphatase (PAP), especially those identified as PAP.135 and PAP.161. The nucleic acid molecules encoding the peptides, antibodies against the peptides, and the use of such peptides, nucleic acids and antibodies in immunotherapy, vaccines and assays are also included in the scope of the invention.
    Type: Application
    Filed: December 23, 2008
    Publication date: November 4, 2010
    Inventors: Robert Charles Rees, Stephanie Eugenie Brigitte McArdle, Richard John Parkinson
  • Cancer associated genes and their products
    Publication number: 20030180738
    Abstract: The application discloses cancer-associated genes and their products, especially those identifiable by SEREX. The genes and products are used to identify, track and treat cancer. Preferably the cancer is prostate cancer.
    Type: Application
    Filed: November 13, 2002
    Publication date: September 25, 2003
    Inventors: Robert Charles Rees, Geng Li, Shahid Mian
  • Methods for treating cells
    Publication number: 20020041869
    Abstract: Methods for treating cells, e.g. proliferating cells such as tumor cells, comprise exposing them to cell-damaging agents (which can cause indirect damage, e.g. as vectors for delivery of a gene encoding a cytokine or antigen) and to antigen-presenting cells so as to damage them or reduce their proliferation.
    Type: Application
    Filed: June 6, 2001
    Publication date: April 11, 2002
    Applicant: The Nottingham Trent University and Cantab Pharmaceuticals Research Limited
    Inventors: Selman Abdul-Halim Ali, June Lynam, Robert Charles Rees, Cornelia Suzanna McLean
  • Insulin-like growth factor II as antitumour agent
    Patent number: 5902788
    Abstract: The invention relates to the use of IGF-II for the manufacture of a medicament for the treatment of tumours, and especially for the manufacture of a medicament for growth inhibition of melanoma cells and for the treatment of cutaneous melanomas. The medicament can be systemically or locally administered.
    Type: Grant
    Filed: May 15, 1996
    Date of Patent: May 11, 1999
    Assignee: Pharmacia & Upjohn Aktiebolag
    Inventors: Paul Schofield, Robert Charles Rees, Amardip Singh Bhuller, Anna Skottner-Lundin